Mecwins
Madrid
About Mecwins
Mecwins develops technology for nanomechanical sensing and uses its technology to produce sensitive immunoassays for oncology, cardiovascular disease, and infectious diseases. They improve the healthcare of those sections of the population who are particularly at risk.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.5M
- Funding stage: Early Stage Venture
- Last round: Grant (Jan 2019)
- Website: mecwins.com
- Phone: +34 918 049 064
Industries & Categories
Biopharma, Biotechnology, Health Care, Information Technology, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/mecwins-195823 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.